p.92 抽出テキスト

(Prospective Randomized Milrinone Survival Evaluation) Investigators. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. Circulation 2000; 101: 40-46. PMID: 10618302 4 8 6 .Di Marco A, Anguera I, Schmitt M, et al. Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: Systematic review and meta-analysis. JACC Heart Fail 2 0 1 7 ; 5 : 2 8 - 3 8 . PMID: 28017348 487. Piers SR, Tao Q, van Huls van Taxis CF, et al. Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: Implications for the ablation strategy. Circ Arrhythm Electrophysiol 2013; 6: 875- 883. PMID: 24036134 488. Hilfiker G, Schoenenberger AW, Erne P, et al. Utility of electrophysiological studies to predict arrhythmic events. World J Cardiol 2015; 7: 344-350. PMID: 26131339 489.Brugada P, Brugada J, Mont L, et al. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 1991; 83: 1649-1659. PMID: 2022022 490. Steinman RT, Herrera C, Schuger CD, et al. Wide QRS tachycardia in the conscious adult. Ventricular tachycardia is the most frequent cause. JAMA 1989; 261: 1013-1016. PMID: 2915409 491. Chinushi M, Aizawa Y, Takahashi K, et al. Radiofrequency catheter ablation for idiopathic right ventricular tachycardia with special reference to morphological variation and long-term outcome. Heart 1997; 78: 255-261. PMID: 9391287 492. Nogami A, Naito S, Tada H, et al. Demonstration of diastolic and presystolic Purkinje potentials as critical potentials in a macroreentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia. J Am Coll Cardiol 2000; 36: 811-823. PMID: 10987604 493. Huizar JF, Ellenbogen KA, Tan AY, et al. Arrhythmia-induced cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 2019; 73: 2328-2344. PMID: 31072578 494. Wever EF, Hauer RN, van Capelle FL, et al. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 1995; 91: 2195-2203. PMID: 7697849 495.Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J 1994; 127: 1139-1144. PMID: 8160593 496. Connolly SJ, Hallstrom AP, Cappato R, et al. Investigators of the AVID, CASH and CIDS studies. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J 2000; 21: 2071-2078. PMID: 11102258 497. Gheeraert PJ, De Buyzere ML, Taeymans YM, et al. Risk factors for primary ventricular fibrillation during acute myocardial infarction: a systematic review and meta-analysis. Eur Heart J 2006; 27: 2499-2510. PMID: 16952926 498. Mont L, Cinca J, Blanch P, et al. Predisposing factors and prognostic value of sustained monomorphic ventricular tachycardia in the early phase of acute myocardial infarction. J Am Coll Cardiol 1996; 28: 1670-1676. PMID: 8962550 499. Naruse Y, Tada H, Harimura Y, et al. Early repolarization is an independent predictor of occurrences of ventricular fibrillation in the very early phase of acute myocardial infarction. Circ Arrhythm Electrophysiol 2012; 5: 506-513. PMID: 22534250 500. Naruse Y, Nogami A, Harimura Y, et al. Difference in the clinical characteristics of ventricular fibrillation occurrence in the early phase of an acute myocardial infarction between patients with and without J waves. J Cardiovasc Electrophysiol 2015; 26: 872-878. PMID: 25895076 501. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1297-1302. PMID: 10725290 502. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748- 754. PMID: 10942742 503. Selvanayagam JB, Hartshorne T, Billot L, et al. Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial. Ann Noninvasive Electrocardiol 2017; 22: e12420. PMID: 28117536 504. Gardner MJ, Montague TJ, Armstrong CS, et al. Vulnerability to ventricular arrhythmia: assessment by mapping of body surface potential. Circulation 1986; 73: 684-692. PMID: 3948371 505. Weismüller P, Abraham-Fuchs K, Killmann R, et al. Magnetocardiography: Three-dimensional localization of the origin of ventricular late fields in the signal averaged magnetocardiogram in patients with ventricular late potentials. Eur Heart J 1993; 14 Suppl E: 61-68. PMID: 8223757 506. On K, Watanabe S, Yamada S, et al. Integral value of JT interval in magnetocardiography is sensitive to coronary stenosis and improves soon after coronary revascularization. Circ J 2007; 71: 1586-1592. PMID: 17895556 507. Desai AS, Fang JC, Maisel WH, et al. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: A meta-analysis of randomized controlled trials. JAMA 2004; 292: 2874-2879. PMID: 15598919 508. Grimm W, Christ M, Bach J, et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: Results of the Marburg Cardiomyopathy Study. Circulation 2003; 108: 2883-2891. PMID: 14623812 509. Das MK, Maskoun W, Shen C, et al. Fragmented QRS on twelvelead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy. Heart Rhythm 2010; 7: 74-80. PMID: 20129288 510.Kuruvilla S, Adenaw N, Katwal AB, et al. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: A systematic review and meta-analysis. Circ Cardiovasc Imaging 2014; 7: 250-258. PMID: 24363358 511. Matsumori A, Furukawa Y, Hasegawa K, et al. Epidemiologic and clinical characteristics of cardiomyopathies in Japan: Results from nationwide surveys. Circ J 2002; 66: 323- 336. PMID: 11954944 512. Maron BJ, Savage DD, Wolfson JK, et al. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study. Am J Cardiol 1981; 48: 252-257. PMID: 7196685 513. McKenna WJ, England D, Doi YL, et al. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. Br Heart J 1981; 46: 168-172. PMID: 7196768 514. Stewart JT, McKenna WJ. Arrhythmias in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 1991; 2: 516-524. 515. Weng Z, Yao J, Chan RH, et al. Prognostic value of LGE-CMR in HCM: A meta-analysis. JACC Cardiovasc Imaging 2016; 9: 1392-1402. PMID: 27450876 516. Kuck KH, Kunze KP, Schlüter M, et al. Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. Eur Heart J 1988; 9: 177-185. PMID: 3280318 517. Zhu DW, Sun H, Hill R, et al. The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 1998; 21: 299-302. PMID: 9474693 518. Wada Y, Aiba T, Matsuyama TA, et al. Clinical and pathological impact of tissue fibrosis on lethal arrhythmic events in hypertrophic cardiomyopathy patients with impaired systolic function. Circ J 2015; 79: 1733-1741. PMID: 26016925 519. Kulakowski P, Counihan PJ, Camm AJ, et al. The value of time and frequency domain, and spectral temporal mapping analysis of the signal-averaged electrocardiogram in identification of patients with hypertrophic cardiomyopathy at increased risk of sudden death. Eur Heart J 1993; 14: 941-950. PMID: 8375420 520. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 2018; 138: e 272-e 391. PMID: 29084731 521. Nollert G, Fischlein T, Bouterwek S, et al. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol 1997; 30: 1374-1383. PMID: 9350942 522. Nakazawa M, Shinohara T, Sasaki A, et al. Arrhythmias late after repair of tetralogy of fallot: A Japanese Multicenter Study. Circ J 2004; 68: 126 -130. PMID: 14745146 523. Furushima H, Chinushi M, Sugiura H, et al. Ventricular tachycardia late after repair of congenital heart disease: efficacy of combination therapy with radiofrequency catheter ablation and class III antiarrhythmic agents and long-term outcome. J Electrocardiol 2006; 39: 219-224. PMID: 16580423 524. Ghai A, Silversides C, Har ris L, et al. Left ventricular